AG
GMAB icon

AmeriFlex Group’s Genmab GMAB Stock Holding History

AmeriFlex Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
+122
New +$3.24K ﹤0.01% 1132
2025
Q2 		– Sell
-44
Closed -$862 – 1146
2025
Q1 		$862 Hold
44
– – ﹤0.01% 1213
2024
Q4 		$865 Buy
+44
New +$967 ﹤0.01% 1108

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AmeriFlex Group's GMAB Position: Q2 2026 in Review

AmeriFlex Group opened a new position in Genmab (GMAB) in Q2 2026: 122 shares worth $3.35K. The stake represents ﹤0.01% of the portfolio and ranks #1132 among its holdings. This is a return to the name: AmeriFlex Group previously reported a position in GMAB as recently as Q1 2025.

AmeriFlex Group first reported a position in GMAB in Q4 2024 and has held it in 3 quarters since. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • AmeriFlex Group held 122 shares of Genmab worth $3.35K as of Q2 2026.
  • Genmab was a new AmeriFlex Group position in Q2 2026.
  • Genmab made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1132 holding.
  • AmeriFlex Group first reported a position in Genmab in Q4 2024 and has held it in 3 quarters since.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.